Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |